Financhill
Sell
34

MLSS Quote, Financials, Valuation and Earnings

Last price:
$0.93
Seasonality move :
-5.1%
Day range:
$0.89 - $0.95
52-week range:
$0.54 - $1.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.04x
P/B ratio:
9.82x
Volume:
54.3K
Avg. volume:
97.9K
1-year change:
29.33%
Market cap:
$70.9M
Revenue:
$9.8M
EPS (TTM):
-$0.07

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MLSS
Milestone Scientific
$2.7M -$0.01 17.38% -66.67% --
ALGN
Align Technology
$999.2M $2.45 -1.71% 44.8% $254.64
BIOLQ
Biolase
$13.5M -$0.01 3.78% -99.71% $1.2000
NVST
Envista Holdings
$645.9M $0.22 -2.29% 51.15% $21.33
SONX
Sonendo
-- -- -- -- --
XRAY
Dentsply Sirona
$920.3M $0.43 -10.31% 232.77% $20.20
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MLSS
Milestone Scientific
$0.91 -- $70.9M -- $0.00 0% 8.04x
ALGN
Align Technology
$169.59 $254.64 $12.5B 30.23x $0.00 0% 3.18x
BIOLQ
Biolase
$0.0081 $1.2000 $295.7K -- $0.00 0% 0.00x
NVST
Envista Holdings
$17.17 $21.33 $3B -- $0.00 0% 1.18x
SONX
Sonendo
-- -- -- -- $0.00 0% --
XRAY
Dentsply Sirona
$15.56 $20.20 $3.1B -- $0.16 4.11% 0.83x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MLSS
Milestone Scientific
-- 2.706 -- 1.42x
ALGN
Align Technology
-- 2.453 -- 1.02x
BIOLQ
Biolase
142.17% 1.859 714.45% 0.23x
NVST
Envista Holdings
32.21% 1.056 41.98% 1.63x
SONX
Sonendo
-- 0.000 -- --
XRAY
Dentsply Sirona
52.37% 0.344 56.57% 0.55x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MLSS
Milestone Scientific
$1.8M -$1.5M -61.33% -61.33% -58.44% -$973.9K
ALGN
Align Technology
$696.9M $177.1M 11.12% 11.12% 17.79% $263.1M
BIOLQ
Biolase
$4.4M -$695K -129.74% -21668.17% -7.48% -$4.5M
NVST
Envista Holdings
$372.5M $67.7M -22.7% -32.33% 7.11% $123.8M
SONX
Sonendo
-- -- -- -- -- --
XRAY
Dentsply Sirona
$446M $9M -18.42% -32.39% -56.02% $36M

Milestone Scientific vs. Competitors

  • Which has Higher Returns MLSS or ALGN?

    Align Technology has a net margin of -58.13% compared to Milestone Scientific's net margin of 10.43%. Milestone Scientific's return on equity of -61.33% beat Align Technology's return on equity of 11.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
    ALGN
    Align Technology
    70.03% $1.39 $3.9B
  • What do Analysts Say About MLSS or ALGN?

    Milestone Scientific has a consensus price target of --, signalling upside risk potential of 133.52%. On the other hand Align Technology has an analysts' consensus of $254.64 which suggests that it could grow by 50.15%. Given that Milestone Scientific has higher upside potential than Align Technology, analysts believe Milestone Scientific is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    MLSS
    Milestone Scientific
    0 0 0
    ALGN
    Align Technology
    9 5 0
  • Is MLSS or ALGN More Risky?

    Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Align Technology has a beta of 1.687, suggesting its more volatile than the S&P 500 by 68.738%.

  • Which is a Better Dividend Stock MLSS or ALGN?

    Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Align Technology pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MLSS or ALGN?

    Milestone Scientific quarterly revenues are $2.5M, which are smaller than Align Technology quarterly revenues of $995.2M. Milestone Scientific's net income of -$1.5M is lower than Align Technology's net income of $103.8M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Align Technology's PE ratio is 30.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.04x versus 3.18x for Align Technology. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MLSS
    Milestone Scientific
    8.04x -- $2.5M -$1.5M
    ALGN
    Align Technology
    3.18x 30.23x $995.2M $103.8M
  • Which has Higher Returns MLSS or BIOLQ?

    Biolase has a net margin of -58.13% compared to Milestone Scientific's net margin of -13.16%. Milestone Scientific's return on equity of -61.33% beat Biolase's return on equity of -21668.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
    BIOLQ
    Biolase
    40.39% -$0.04 $12.4M
  • What do Analysts Say About MLSS or BIOLQ?

    Milestone Scientific has a consensus price target of --, signalling upside risk potential of 133.52%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 24652.48%. Given that Biolase has higher upside potential than Milestone Scientific, analysts believe Biolase is more attractive than Milestone Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    MLSS
    Milestone Scientific
    0 0 0
    BIOLQ
    Biolase
    1 1 0
  • Is MLSS or BIOLQ More Risky?

    Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Biolase has a beta of 0.817, suggesting its less volatile than the S&P 500 by 18.311%.

  • Which is a Better Dividend Stock MLSS or BIOLQ?

    Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MLSS or BIOLQ?

    Milestone Scientific quarterly revenues are $2.5M, which are smaller than Biolase quarterly revenues of $10.9M. Milestone Scientific's net income of -$1.5M is lower than Biolase's net income of -$1.4M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.04x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MLSS
    Milestone Scientific
    8.04x -- $2.5M -$1.5M
    BIOLQ
    Biolase
    0.00x -- $10.9M -$1.4M
  • Which has Higher Returns MLSS or NVST?

    Envista Holdings has a net margin of -58.13% compared to Milestone Scientific's net margin of 0.18%. Milestone Scientific's return on equity of -61.33% beat Envista Holdings's return on equity of -32.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
    NVST
    Envista Holdings
    57.05% $0.01 $4.3B
  • What do Analysts Say About MLSS or NVST?

    Milestone Scientific has a consensus price target of --, signalling upside risk potential of 133.52%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 24.25%. Given that Milestone Scientific has higher upside potential than Envista Holdings, analysts believe Milestone Scientific is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    MLSS
    Milestone Scientific
    0 0 0
    NVST
    Envista Holdings
    3 10 1
  • Is MLSS or NVST More Risky?

    Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.326, suggesting its more volatile than the S&P 500 by 32.59%.

  • Which is a Better Dividend Stock MLSS or NVST?

    Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MLSS or NVST?

    Milestone Scientific quarterly revenues are $2.5M, which are smaller than Envista Holdings quarterly revenues of $652.9M. Milestone Scientific's net income of -$1.5M is lower than Envista Holdings's net income of $1.2M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.04x versus 1.18x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MLSS
    Milestone Scientific
    8.04x -- $2.5M -$1.5M
    NVST
    Envista Holdings
    1.18x -- $652.9M $1.2M
  • Which has Higher Returns MLSS or SONX?

    Sonendo has a net margin of -58.13% compared to Milestone Scientific's net margin of --. Milestone Scientific's return on equity of -61.33% beat Sonendo's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
    SONX
    Sonendo
    -- -- --
  • What do Analysts Say About MLSS or SONX?

    Milestone Scientific has a consensus price target of --, signalling upside risk potential of 133.52%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Milestone Scientific has higher upside potential than Sonendo, analysts believe Milestone Scientific is more attractive than Sonendo.

    Company Buy Ratings Hold Ratings Sell Ratings
    MLSS
    Milestone Scientific
    0 0 0
    SONX
    Sonendo
    0 0 0
  • Is MLSS or SONX More Risky?

    Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock MLSS or SONX?

    Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MLSS or SONX?

    Milestone Scientific quarterly revenues are $2.5M, which are larger than Sonendo quarterly revenues of --. Milestone Scientific's net income of -$1.5M is higher than Sonendo's net income of --. Notably, Milestone Scientific's price-to-earnings ratio is -- while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.04x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MLSS
    Milestone Scientific
    8.04x -- $2.5M -$1.5M
    SONX
    Sonendo
    -- -- -- --
  • Which has Higher Returns MLSS or XRAY?

    Dentsply Sirona has a net margin of -58.13% compared to Milestone Scientific's net margin of -47.51%. Milestone Scientific's return on equity of -61.33% beat Dentsply Sirona's return on equity of -32.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    MLSS
    Milestone Scientific
    73.05% -$0.02 $7.2M
    XRAY
    Dentsply Sirona
    49.28% -$2.16 $4.1B
  • What do Analysts Say About MLSS or XRAY?

    Milestone Scientific has a consensus price target of --, signalling upside risk potential of 133.52%. On the other hand Dentsply Sirona has an analysts' consensus of $20.20 which suggests that it could grow by 28.54%. Given that Milestone Scientific has higher upside potential than Dentsply Sirona, analysts believe Milestone Scientific is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    MLSS
    Milestone Scientific
    0 0 0
    XRAY
    Dentsply Sirona
    2 11 0
  • Is MLSS or XRAY More Risky?

    Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.383%.

  • Which is a Better Dividend Stock MLSS or XRAY?

    Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.11% to investors and pays a quarterly dividend of $0.16 per share. Milestone Scientific pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

  • Which has Better Financial Ratios MLSS or XRAY?

    Milestone Scientific quarterly revenues are $2.5M, which are smaller than Dentsply Sirona quarterly revenues of $905M. Milestone Scientific's net income of -$1.5M is higher than Dentsply Sirona's net income of -$430M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.04x versus 0.83x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MLSS
    Milestone Scientific
    8.04x -- $2.5M -$1.5M
    XRAY
    Dentsply Sirona
    0.83x -- $905M -$430M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock